Due to the size of this blog post, we have moved the information to a dedicated page on our website. You may access the page by clicking the following link:
March 24, 2020
By RapidMicro
In: Coronavirus, diagnostic, Emergency Use Authorization, EUA, FDA, SARS-CoV-2, serology
3 comments
By RapidMicro
In: Coronavirus, diagnostic, Emergency Use Authorization, EUA, FDA, SARS-CoV-2, serology
3 comments
great
ReplyDeleteexcellent. Can you explain why so many companies have gone in for RT PCR and why RT LAMP which would have given results at point of care leading to isolation and interruption of transmission have not found favour with both the companies or regulatory authorities ?
ReplyDeleteGreat question. This may have more to do with patent protection for the newer LAMP methods as compared with conventional RT-PCR methods.
Delete